Related by context. All words. (Click for frequent words.) 76 Recombinant Human 76 Fibrinogen 73 Lymphoid 73 Meets Primary Endpoint 73 Progenitor Cells 72 Prolongs Survival 72 Factor Receptor 72 Hematopoietic 72 Smooth Muscle 72 Dehydrogenase 72 vapreotide acetate 72 Antitumor Activity 72 soluble tumor necrosis 72 Granulocyte Colony Stimulating Factor 72 Pulmonary Arterial Hypertension 71 Tyrosine Kinase Inhibitor 71 Gamunex C 71 Glucocorticoid 71 Completes Patient Enrollment 71 Tumor Targeting 71 Novel Compound 71 HuMax TAC 71 Novel Oral 71 Shows Promise Against 71 Oral Fingolimod 71 Zorbtive TM 71 Drug Candidate 71 Signaling Pathway 71 Kinase Inhibitor 71 von Willebrand Factor 71 Epidermal Growth Factor Receptor 71 Novel Therapeutic 71 Anti Tumor 71 Thiazolidinediones 71 Improves Survival 71 Adenoviral 71 NDA Submission 71 Monoclonal 71 Therapeutic Efficacy 71 protein tyrosine phosphatase 1B 71 Sapacitabine 71 Immunotherapeutic 71 Phase 2b Trial 71 Transdermal Delivery 70 Files IND 70 Initiate Clinical Trial 70 Treating Chronic 70 GTC recombinant form 70 Skeletal Muscle 70 Immune Globulin Intravenous 70 Methylnaltrexone 70 Transdermal Patch 70 Phase 2a Clinical Trial 70 Liprotamase 70 Soluble CD# 70 C1 Inhibitor 70 Diabetic Neuropathy 70 Allogeneic 70 Receives Orphan Drug Designation 70 Romiplostim 70 Successfully Completes Phase 70 Initiates Clinical 70 Adipose Derived Stem Cells 70 pathophysiological effects 70 First Patient Dosed 70 Phase 2b Clinical Trial 70 Diabetic Foot Ulcer 70 Initiates Enrollment 70 Hypercholesterolemia 70 Bone Metastases 70 R Saizen R 70 Teva Provides Update 70 Alpha1 Proteinase Inhibitor 70 Lymphocytic 70 Thrombin 70 Improves Outcomes 70 Clinical Outcome 70 Initiates Clinical Trial 70 Parathyroid Hormone 70 FS Antihemophilic Factor Recombinant 70 Tissue Engineered 70 Immunomodulatory 70 Hepatocytes 70 Initiates Phase II 69 See CLINICAL PHARMACOLOGY 69 Endothelial Cells 69 PEGylated anti 69 Initiates Dosing 69 Remission Maintenance 69 Antitumor 69 Antigen Specific 69 interleukin IL -# 69 Attenuates 69 Mg Usa 69 Modulates 69 Levels Linked 69 Mg Uk 69 Mouse Model 69 Adjuvant Treatment 69 CYP#A# CYP#D# 69 FDA Okays 69 Kuvan sapropterin dihydrochloride 69 Novel Mechanism 69 Phase 2a Trial 69 Mouse Models 69 Cytarabine 69 Estrogen Receptor 69 FDA Approvals 69 Plasmin 69 Tumor Suppressor Gene 69 Metabolic Disorder 69 Seasonal Influenza Vaccine 69 bFGF 69 Bone Morphogenetic Protein 69 small molecule thrombopoietin 69 Single Dose 69 Demonstrates Significant 69 Dendritic Cells 69 Hsp# Inhibitor 69 Subunit 69 Orally administered 69 Complicated Skin 69 Dupuytren Contracture 69 Secretase 69 Adjuvant Chemotherapy 69 Inhibits 69 Technosphere ® 69 Fibroblast Growth Factor 69 Epithelial 69 Node Positive 69 Novel Small Molecule 69 Test Detects 69 Phase III Clinical Trial 69 Interferon Gamma 69 Drug Shows Promise 69 Platelet rich 69 Angiotensin II 69 Investigational Treatment 69 Extracellular Matrix 69 AnaSpec Introduces 68 Anti Tumor Activity 68 Hepatitis C Genotype 68 Hormone Refractory Prostate Cancer 68 Oral Formulation 68 RNAi Therapeutic 68 Incretin 68 Angiotensin Converting Enzyme 68 Gene Variation 68 Lowers Risk 68 Study Evaluating 68 Intravascular 68 R lenalidomide 68 Serostim ® 68 Patients Treated With 68 Protein Linked 68 Immunomedics Announces 68 Aurora Kinase 68 Phase IIb Trial 68 Raw #/#/# Punjab 68 Randomized Double blind 68 Immunosuppressant 68 Angiotensin 68 hyaluronidase rHuPH# 68 Prolactin 68 factor TNF receptor 68 busulfan 68 JAK Inhibitor 68 HDAC Inhibitor 68 Bucindolol 68 Treatment Reduces 68 Plaque Psoriasis 68 Interferon gamma 68 Shows Promising 68 Fungal Infections 68 Study Shows Benefits 68 ALN HPN 68 Sevelamer 68 Tumor Response 68 Cell Adhesion 68 prostanoid 68 Tumor Suppressor 68 Interferons 68 Preclinical Study 68 Retinoic Acid 68 Systemic Delivery 68 TNF Tumor Necrosis Factor 68 Confirmatory Phase 68 Renal Impairment 68 Reductase 68 Neuroprotection 68 myelofibrosis polycythemia vera 68 Submits NDA 68 Critically Ill Patients 68 Tezampanel 68 Tumor Necrosis Factor 68 Achieves Primary Endpoint 68 Unfractionated Heparin 68 Aerosolized 68 ABLYNX 68 Novel Anti Inflammatory 68 Antibody Discovery 68 Chronic Liver Disease 68 Regenerative Cells 68 Renal Function 68 Vitrasert R 68 Decitabine 68 developing Bicifadine serotonin 68 Left Ventricular 68 Cytochrome P# 68 Ischemic 68 Significantly Improves 68 Dural Regeneration Matrix 68 Combination Treatment 68 FDA Clears 68 Inactivation 68 Genes Involved 68 5 Fluorouracil 68 Immunosuppression 68 Spinal Fluid 68 Chemokine Receptor 68 Vaccine Adjuvants 68 Vertebral Fractures 68 Immune Cell 68 Receptor Agonist 68 Lyophilized 68 Receptor Antagonists 68 Progenitor Cell 68 ADAMTS# 68 Inflammatory Markers 68 matrix metalloproteinases MMPs 68 Diabetic Nephropathy 68 Secondary Hyperparathyroidism 68 Mucosal 68 Vascular Inflammation 67 Radiation Induced 67 Epratuzumab 67 HepaLife TM 67 Lubiprostone 67 Immune Globulin 67 Clinical Study Shows 67 Mimetics 67 CYT# potent vascular disrupting 67 Inhaled Corticosteroids 67 Renal Cancer 67 Well Tolerated 67 Microalbuminuria 67 cromolyn sodium 67 Aeolus Pharmaceuticals Announces 67 Demonstrates Potential 67 Recombinant Protein 67 AVI BioPharma Announces 67 Peripheral Blood 67 carcinoids originate 67 Replacement Therapy 67 Interferon Beta 67 CFTR cystic fibrosis transmembrane 67 Slows Progression 67 Aliskiren 67 Thrombotic 67 Monoclonal Antibody 67 Autologous 67 Sustained Release 67 Glucocorticoids 67 Thyroid Hormone 67 Inflammatory Diseases 67 Muscarinic 67 directed radiotherapeutic antibody 67 hyaluronidase enzyme 67 5 HT6 receptor 67 Novel Antibiotic 67 Plasmid DNA 67 Nucleoside 67 Blood Clotting 67 Oral Calcitonin 67 Appears Safe 67 Ancrod 67 Adjunctive Therapy 67 peptidic compound 67 Synthetic Peptide 67 Drug Prevents 67 Initiates Clinical Trials 67 Respiratory Virus 67 Prospective Randomized 67 Aloprim TM allopurinol sodium 67 alpha1 proteinase inhibitor 67 Initiates Phase III 67 Pegylated 67 Excretion 67 Demonstrates Sustained 67 Oral Insulin 67 Receives Approvable Letter 67 downregulates 67 Granted Orphan Drug 67 Clinical Trial Evaluating 67 Antiviral Drugs 67 Fondaparinux 67 TO AVOID PREGNANCY WHILE 67 Autoantibodies 67 TNF alpha selectively neutralizing 67 Small Molecule 67 Angiogenic 67 Nebulized 67 Malignant Glioma 67 Immune Responses 67 Protein Kinase C 67 Tumor Growth 67 Calcitonin 67 Interferon Alpha 67 Placental 67 Monocytes 67 Prodarsan R 67 Hizentra ® 67 Aptamer 67 Previously Treated 67 Androgen 67 Phospholipase A2 67 Completes Enrollment 67 Breast Cancer Metastasis 67 Lowers Blood Pressure 67 Successfully Treats 67 Initiate Phase 67 Crit Rev 67 Proliferative 67 Dry Powder Inhalers 67 AAG geldanamycin analog 67 Oral Spray 67 Upregulation 67 peptide hormone 67 Shows Efficacy 67 Treatment Naïve 67 thymosin beta 4 67 pralatrexate injection folate analogue 67 Glucagon Like Peptide 67 Preclinical Data 67 Orally Active 67 Fracture Risk 67 Humanized Anti 67 Disease Progression 67 Gastric Cancer 67 Pulsatile 67 docetaxel Taxotere ® 67 Glufosfamide 67 arginine vasopressin AVP 67 Prostate Cancer Vaccine 67 coagulation factors 67 Disease Modifying 67 Endothelin 67 BioElectronics Corporation Announces 67 Factor VEGF 67 Fibrin Sealant 67 Macrophage 67 Gout Drug 67 Blood Pressure Drug 67 DNA Methylation 67 Announces FDA Clearance 67 Genetic Variation 67 Predict Risk 67 Hematopoietic Stem Cells 67 von Willebrand factor 67 Advanced Renal Cell 67 SUTENT ® 67 Vaccine Protects Against 67 HepaGam B TM 67 Metastatic Melanoma 67 Low Dose 67 Transcription Factor 67 Insulin Resistance 67 Parenteral Nutrition 67 vWF 67 Anti Inflammatory Drug 67 Factor XIII 67 acetonide FA 67 Combo Therapy 67 Nitazoxanide 67 Anthrax Toxin 67 Hypertensive Patients 66 Liposomal 66 topoisomerase II inhibitor 66 chronic eosinophilic leukemia 66 benzoic acid hyoscyamine sulfate 66 Safinamide 66 Pafuramidine 66 dihydrochloride 66 Bosutinib 66 Gets FDA Clearance 66 Dose Escalation 66 kidney urologic 66 Biolimus A9 66 Breast Cancer Cells 66 Glycosylation 66 Gene Linked 66 Postmenopausal Osteoporosis 66 ADP receptor antagonist 66 Phase III Trial 66 Preclinical Models 66 Erythropoietin 66 Myocardial Perfusion Imaging 66 Present Preclinical Data 66 Talabostat 66 Factor VIIa 66 Posaconazole 66 methylnaltrexone bromide 66 Anticoagulant 66 Maribavir 66 Kidney Transplant Patients 66 ACE Inhibitors 66 Advanced Melanoma 66 Patients Receiving 66 Soy Isoflavones 66 Effectively Treats 66 BioSante Pharmaceuticals Announces 66 Warfarin Coumadin 66 uricase 66 Therapy Improves 66 Growth Hormone Deficiency 66 Impairs 66 Randomized Phase II 66 Protein Kinase 66 Therapeutic Competitors Report 66 Therapeutic Vaccine 66 Eculizumab 66 Hypoxia Inducible Factor 66 Embolization 66 Pegloticase 66 Cholesterol Lowering Drug 66 colony stimulating factor 66 Novel Protein 66 Is Well Tolerated 66 monocytes macrophages 66 Secretory 66 vitamin B# folic acid 66 coronary vasodilation 66 Metabolic Endocrinology 66 Antifungal 66 Cell Transplants 66 Leukemias 66 Immunoglobulin 66 Rotavirus Vaccine 66 2 methoxyestradiol 66 Minimally Invasive Treatment 66 Cardiomyocytes 66 Phase 1b Clinical Trial 66 targeted radiotherapeutic 66 Genotyping Test 66 Catheter Associated 66 Aldosterone 66 Enzyme Replacement Therapy 66 Presents Preclinical Data 66 Epstein Barr Virus EBV 66 Vaccine Adjuvant 66 Severe Sepsis 66 Molecular Mechanism 66 Lung Cancer Drug 66 Protease 66 nucleoside analog 66 Iron Overload 66 Heart Transplant Recipients 66 Stem Cell Derived 66 P2Y 66 Protein Synthesis 66 agonistic human 66 Phase IIb Clinical Trial 66 Mycophenolate Mofetil 66 Chronic Renal Failure 66 Polymorphisms 66 Antisense Drug 66 Aviptadil 66 Surgical Hemostat 66 Alprostadil 66 Innate Immune 66 Intracerebral Hemorrhage 66 Refractory Hodgkin Lymphoma 66 Develops Novel 66 PEGylated Fab fragment 66 Autologous Stem Cell Transplantation 66 Epitope 66 Contrast Agents 66 Neovascular Age Related Macular 66 Abdominal Fat 66 vinorelbine tartrate 66 Therapy Reduces 66 proprietary polysaccharide 66 Anticancer Agent 66 IND Application 66 Secretion 66 Trial Evaluating 66 Phosphorylation 66 Genes Linked 66 Recurrent Breast Cancer 66 Fluconazole 66 Treatment Shows Promise 66 Platelet Derived Growth 66 investigational oral inhibitor 66 Therapeutic Competitors Companies 66 % Caprylate Chromatography 66 LymphoStat B belimumab 66 Febuxostat 66 urate oxidase 66 Haemophilus b Conjugate 66 oral dual endothelin 66 Annexin A5 66 Polymerase Inhibitor 66 Sumatriptan Succinate 66 Gene Variants 66 Antiangiogenic 66 anti CD3 66 Induces Apoptosis 66 Simulect 66 Tubulin 66 Phase Ib Clinical Trial 66 Immune Globulin Subcutaneous 66 Osteoporosis Treatment 66 Statin Drugs 66 Mylan Receives Approval 66 HER2 Positive 66 Infected Patients 66 BUPHENYL R 66 Melphalan 66 Viral Infections 66 Controlled Trial 66 Hyperkalemia 66 Medoxomil 66 Tesamorelin 66 octreotide acetate 66 Protease Inhibitor 66 Demonstrates Efficacy 66 PRN FDA Approves 66 Improve Survival 66 FDA Warns Against 66 Portal Hypertension 66 Poorly Controlled 66 Polymerase 66 Slow Progression 66 platelet dysfunction 66 Schizophrenia Treatment 66 Protein Expression 66 C1 Esterase Inhibitor 66 epoetin delta 66 uroguanylin 66 A1PI 66 Neurogenesis 66 Immune Therapy 66 Bioavailability 66 Submits Response 66 humanized monoclonal 66 Relapsed Refractory 66 Oral Mucositis 66 Ovitrelle R Serostim 66 Therapeutic Potential 66 Nilotinib 66 intravesical infusion therapy 66 Nanoemulsion 66 Hyaluronidase 66 iobenguane 66 Protein Interactions 66 Chemotherapeutic Agents 66 Clinical Trial Results 66 Golimumab 66 Liver Tumors 66 Acute Ischemic Stroke 66 Investigational eFlow Nebulizer System 66 Adult Stem Cell Therapy 66 Tacrolimus 66 Gastrointestinal Stromal Tumors 66 Multicenter Randomized 66 Radiofrequency Ablation 66 HuCAL PLATINUM ® CysDisplay 66 blood clotting protein 66 Pramlintide 66 Myeloperoxidase 66 Milestone Payment 66 Kinase Inhibitors 66 Neurotransmitter 66 Endologix Powerlink System 66 P#Y# [001] 66 Tiotropium 66 Progressive Multifocal Leukoencephalopathy 66 Predict Response 66 Neovascularization 66 Int J Obes Relat 66 Peroxisome Proliferator Activated Receptor 66 Cholesterol Lowering 66 Commence Phase 66 Teriparatide 66 Brimonidine 66 Vaginal Gel 66 Statistically Significant 66 Fluticasone 65 Myeloma Patients 65 sapropterin dihydrochloride 65 underlying vasculopathy 65 Proteasome 65 Tocopherol 65 plasmid encoding 65 selective modulator 65 Fast Track Status 65 IMiDs ® compound 65 Relapsing Multiple Sclerosis 65 FDA Accepts 65 Levaquin levofloxacin 65 Demonstrates Positive 65 GRAS Status 65 Proven Effective 65 Hepatocellular 65 Myoblast 65 Disease IBD 65 Phase IIa Clinical Trial 65 Protein Involved 65 Symptom Relief 65 Announcement acc 65 Novel Inhibitor 65 Transcriptome 65 Pruvel TM 65 Am J Clin 65 Prostaglandin 65 GTC recombinant human 65 candidates Azedra TM 65 Liver Injury 65 Dose Response 65 Anti Inflammatory 65 Vascular Grafts 65 Atypical Hemolytic Uremic Syndrome 65 Prolongs Life 65 mediated inhibition 65 Degarelix 65 Double Blind Randomized 65 Investigational Agent 65 non peptidic protease 65 extracellular signal 65 Intracerebral 65 Premature Infants 65 J Am Coll 65 Ebola Vaccine 65 Successfully Treated 65 Budesonide 65 Initiate Phase III 65 Intrathecal 65 Perifosine KRX 65 cMET 65 Commercialize Novel 65 MEK Inhibitor 65 Atopic Dermatitis 65 Kidney Function 65 Reduces Pain 65 Antimicrobial Coating 65 Dasatinib 65 Renin 65 hypereosinophilic syndrome 65 Increased Mortality 65 Ribavirin causes 65 somatotropin 65 Inhalation Solution 65 Lactoferrin 65 Cerebrospinal Fluid 65 phenyl salicylate methylene blue 65 Fibroblast 65 Clin J 65 Generic Versions 65 vitreoretinal disorders 65 chimeric monoclonal antibody 65 Prodrugs 65 FDA APPROVES 65 ergot derivatives 65 endoluminal stent graft 65 oral prodrug 65 Randomized Study 65 Presents Positive 65 cell adhesion molecule 65 Epithelial Cell 65 HCl Injection 65 Inflammatory Pain 65 Endovascular Treatment 65 Asthma COPD 65 Phase III Pivotal 65 MKC# 65 Lowers Cholesterol 65 plasminogen activator inhibitor 65 Saizen ® 65 TRANSDUR ™ 65 Potent Inhibitor 65 factor HGF 65 Naive Patients 65 Guidelines Issued 65 Calcium Supplements 65 Hyperlipidemia 65 inhibit oxidative stress 65 Conjugated 65 Rheumatoid Arthritis Patients 65 Crofelemer budesonide foam 65 CYP#A# substrate 65 Bacteremia 65 Intracellular 65 Postdoctoral Position 65 PRIALT 65 Endometrial 65 Xcellerated T Cells 65 Bepreve TM 65 Prostacyclin 65 Cytotoxic 65 Peptic Ulcer 65 Lupus Drug 65 Alfacell proprietary ribonuclease 65 alpha GAL 65 plasma derived antithrombin 65 Interferon Alfa 65 Signaling Pathways 65 Urocidin TM 65 Nicotine Vaccine 65 ATRA IV 65 Hormone Replacement 65 Transfection 65 Endothelial 65 Personalized Immunotherapy 65 Pharmacokinetic Study 65 Therapeutic Antibody 65 Intravenous Human 65 Rabies Vaccine 65 adrenocorticotropic hormone 65 hydroxocobalamin 65 E1 INT TM 65 Treat Anemia 65 triggers apoptosis 65 M1 muscarinic 65 Prodrug 65 Hyperparathyroidism 65 Investigational eFlow 65 Estradiol 65 essential thrombocythemia ET 65 Clinical Trial Data 65 Renal Cell Carcinoma 65 Lung Cancer Survival 65 Enlarged Prostate 65 AFREZZA TM 65 YONDELIS 65 N Acetyl 65 5 HT4 65 Antiviral Therapy 65 Vinorelbine 65 COPEGUS therapy 65 immune modulatory 65 Pivotal Phase III 65 MKC# MKC# PP 65 Catheter Ablation 65 Interferon alpha 65 Alkaline Phosphatase 65 Cytotoxicity 65 Dendritic Cell 65 Migraine Treatment 65 IN PATIENTS WITH 65 Monocyte 65 CysDisplay R 65 Doripenem 65 bevacizumab Avastin R 65 glucocerebroside primarily 65 Breast Tumor 65 Novel Method 65 Electrical Stimulation 65 Demonstrated Significant 65 Submits Biologics License Application 65 Muscle Wasting 65 Lenalidomide 65 TRANSDUR ® 65 Begins Dosing 65 Miconazole 65 Ganciclovir 65 IV Busulfex 65 Inhaled Nitric Oxide 65 Rheumatoid Arthritis Drug 65 beta 1a 65 Demonstrate Significant 65 Antiplatelet 65 Peginterferon Alfa 2a 65 ATP Adenosine 65 Androgen Receptor 65 Cardiotoxicity 65 Muscle Function 65 HCV Protease Inhibitor 65 Receives Marketing Authorization 65 Dose Ranging Study 65 Submits IND 65 mertansine 65 Artery Disease 65 LEUKINE 65 Metastatic Cancer 65 Hepatocellular Carcinoma 65 Beta Blocker 65 Moxifloxacin 65 FVIIa 65 J Am Acad 65 Resten NG 65 Gene Mutation 65 Maven Semantic 65 Absorbable 65 Inhibitory 65 J Allergy Clin 65 Bazedoxifene 65 #beta HSD1 65 Files Investigational 65 NMDA Receptor 65 Reduces Risk 65 vaginal candidiasis 65 Intra Arterial 65 Hypertriglyceridemia 65 hepatitis B immunoglobulin 65 Interferon alfa 65 rxRNA 65 Interferon beta 65 Pemetrexed 65 Virus Infection 65 Gonal f R 65 Contrast Agent 65 Differentially 65 2A receptor agonist 65 Inhalation Aerosol 65 Treated Patients 65 DGAT1 65 Parathyroid 65 Cell Differentiation 65 Influenza Virus 65 Commences Phase 65 Pooled Analysis 65 retinal ischemia 65 Novel Treatments 65 receptor tyrosine kinase inhibitor 65 Ad5FGF 4 65 Prophylactic Treatment 65 Bacterial Vaginosis 65 Glucagon 65 Synthase 65 DUROS 65 Taxane 65 Wound Dressings 65 Xenograft 65 5 HT3 antagonist 65 SPRIX ® 65 Lysteda 65 Assay Kits 65 Cethromycin 65 JAK2 Inhibitor 65 platform HDL Mimetic 65 Chemoradiation 65 Prognostic Value 65 Neutrophil 65 First Patient Treated 65 diagnostic radiopharmaceutical 65 pan histone deacetylase 65 Squalamine 65 Angioedema 65 Saizen R 65 Investigational Compound 65 antibiofilm 65 cystic fibrosis transmembrane 65 NAVISTAR R 65 covalently bound 65 KL4 Surfactant 65 subcutaneous immunoglobulin 65 Thiamine 65 Data Suggest 65 INSPIRE Trial Phase III 65 Anthracycline 65 tetracycline antibiotic 65 NASH Huntington 65 methyl CpG binding 65 Hedgehog Pathway Inhibitor 65 Chemotherapy Induced 65 Heparins 65 lutropin alfa 65 Preclinical Efficacy 64 Intradermal 64 Uric Acid 64 PEGylated interferon 64 antiapoptotic 64 Deforolimus 64 Molecular Diagnostic Test 64 C1INH 64 Double Blind Placebo 64 Carcinomas 64 exocrine 64 GAMMAGARD LIQUID 64 recombinant adeno associated 64 Cyclooxygenase 2 64 Cathepsin B 64 albumin naturally occurring 64 triiodothyronine 64 brand ciclesonide HFA 64 Anticancer Drug 64 Zalypsis 64 Janus kinase 64 Patient Enrollment 64 POTELLIGENT ® 64 Circulating Tumor Cells 64 Amniotic Fluid 64 amikacin 64 5 HT2A serotonin 64 Metabolites 64 follitropin alfa 64 Contaminant Found 64 Antiviral Activity 64 Cystatin C 64 #mg #mg #mg [003] 64 Treatment Regimen 64 treat benign prostatic 64 Hypertrophy 64 fibrin deposition 64 ATryn ® GTC recombinant 64 Analytical Tool 64 Topical Treatment 64 Pegylated Interferon 64 Inhalation Powder 64 Systemic lupus erythematosus 64 Oncogenic 64 Receptor Antagonist 64 Reperfusion Injury 64 naturally occurring neuroprotective 64 Liver Toxicity 64 Demonstrates Potent 64 NS5b 64 Pivotal Trial 64 Subtype 64 Hyaluronan 64 Streptococcus agalactiae 64 K ras mutations 64 Kinoid 64 BAL# [002] 64 Glatiramer Acetate 64 Susceptibility Testing 64 Inactivated 64 Chronic Sinusitis 64 Aflibercept 64 Confirms Efficacy 64 Brain Metastases 64 Tumor Cell 64 CGRP 64 Azacitidine 64 Drug Resistant 64 Trodusquemine MSI 64 Bone Marrow Stem Cells 64 Vascular Endothelial Growth 64 Hepatic 64 potent suppressor 64 Patients Suffering 64 Receives Orphan Drug 64 Metastatic Colorectal Cancer 64 Protein Biomarker 64 HIF 1a 64 Hepatitis B Vaccine 64 avidin 64 Conjugate 64 Elderly Patients 64 IMiDs ® 64 Levoleucovorin 64 Expanded Indication 64 Thiamin 64 Peptide YY 64 topical gel formulation 64 fosbretabulin 64 FUSILEV enhances 64 lexidronam injection 64 Intravitreal 64 PROSTASCINT R 64 thyrotropin 64 Wellmune WGP 64 GW# [003] 64 Long Term Efficacy 64 Oligonucleotides 64 Liver Failure 64 HCV RNA polymerase 64 highly selective inhibitor 64 liposomal formulation 64 Pandemic Influenza Vaccine 64 acute peripheral arterial 64 Endometrial Cancer 64 virosome 64 Medullary Thyroid Cancer 64 Genetic Marker 64 Calcium Vitamin D 64 HER1 64 Wafer polifeprosan 64 Epilepsy Drug 64 Fibromyalgia Pain 64 Cyclophosphamide 64 Bicalutamide 64 Enzyme Linked 64 FDA Approves Drug 64 Ecallantide 64 Pivotal Phase 64 Hypotension 64 Fatty Acid 64 Intravesical 64 Rotavirus Vaccines 64 TNF Blockers 64 Drug Combo 64 Overactive Bladder 64 Vaccine Candidate 64 Apoptotic 64 investigational pharmacologically unique 64 Adjuvanted 64 Adenosine A2A 64 Metastatic Prostate Cancer